Royalty Pharma plc has successfully completed the internalization of its management structure with overwhelming support from shareholders. This strategic move aims to enhance alignment with shareholders, increase investment returns, and streamline governance. The forward-looking statements in the document highlight the company’s strategies, growth opportunities, and benefits of the internalization transaction, including improved transparency and simplification of its structure. While management’s current beliefs and assumptions inform these statements, readers are advised not to rely solely on them due to potential risks, uncertainties, and variable circumstances that could impact the company’s actual performance. For further insights, refer to Royalty Pharma’s reports filed with the U.S. Securities and Exchange Commission (SEC) on the SEC’s website.
Read more from nasdaq.com
